论文部分内容阅读
第六届欧洲内科肿瘤会议于1980年12月6日至8日在法国尼斯举行,同时举行的还有EORTC(European Organization for Research on Treatment of Cancer欧洲肿瘤治疗研究机构)两年一度的免疫治疗会议。会期三天,出席代表334人,来自法,比,英,美,德,瑞典,阿根廷等14个国家,在一定程度上反映了西方各国在肿瘤化疗和临床肿瘤免疫学方面的进展。大会共提出论文204篇。本文主要介绍本届内科肿瘤会议的一些情况。 比较新的肿瘤化疗方案有以下几个:1.美国Sloan-Kettering研究院报告的治疗睾丸肿瘤的VAB-6方案。方案包括开始诱导治疗三个疗程,每疗程四天。第一天给环磷酰胺600毫克/米~2,静注;
The 6th European Conference on Medical Oncology was held in Nice, France, from December 6th to 8th, 1980. The EORTC (European Organization for Research on Treatment of Cancer) binational immunotherapy conference was also held. . During the three days of the conference, 334 delegates attended the conference, representing 14 countries including France, Belgium, Britain, the United States, Germany, Sweden, and Argentina. To some extent, they reflected the progress of western countries in cancer chemotherapy and clinical tumor immunology. A total of 204 papers were submitted in the conference. This article mainly introduces some cases of the current medical oncology conference. There are several newer cancer chemotherapy protocols: 1. The VAB-6 protocol for the treatment of testicular tumors reported by the Sloan-Kettering Institute in the United States. The protocol includes three courses of induction therapy, four days for each course of treatment. The first day of cyclophosphamide 600 mg / m ~ 2, intravenous injection;